Results 131 to 140 of about 7,789 (204)

Therapeutic Benefit of Upadacitinib in Severe Post-Proctectomy (Class 4) Perianal Crohn’s Disease: A Three-Patient Case Series

L Hanna, Baseer Quraishi, T Pelly, Phillip Lung, Phil Tozer, Ailsa Hart, Serre-Yu Wong, Nick Powell   +7 more
openalex   +1 more source

OP10 Efficacy and safety of upadacitinib in patients with moderately to severely active Crohn’s Disease: results from the U-ENDURE long-term extension [PDF]

Geert D’Haens, Édouard Louis, Edward V. Loftus, Miguel Regueiro, Vipul Jairath, Fernando Magro, Hiroshi Nakase, Elena Dubcenco, Ana P. Lacerda, Ting Feng, Benjamin Duncan, Timothy C. Wang, Sharanya Ford, S. Anyanwu, Irina Blumenstein   +14 more
openalex   +1 more source

Safety and efficacy of different JAK inhibitors in the treatment of inflammatory bowel disease: a network meta-analysis. [PDF]

Front Pharmacol
Wu H, Zhou Y, Chen X, Wang L, Guo Y, Du X, Miao X.   +6 more
europepmc   +1 more source

Upadacitinib as rescue therapy for acute severe ulcerative colitis and severe Crohn’s disease – current knowledge and future directions

Miłosz Caban, Patrycja Dudek, Aleksandra Strigáč, Patrycja Szałwińska, Renata Talar‐Wojnarowska   +4 more
openalex   +2 more sources

Upadacitinib zur Behandlung von gleichzeitig bestehender allergischer Kontaktdermatitis und Psoriasis [PDF]

Peter Ch’en, Miriam Al-Saedy, Eingun James Song   +2 more
openalex   +1 more source

Beneficial effects of upadacitinib on a subgroup of patients with atopic dermatitis and hidradenitis suppurativa: a multicenter, real-world retrospective study. [PDF]

Front Immunol
Russo F, Schettini N, Scaglione GL, Gori N, Manzo Margiotta F, Del Duca E, Bianchelli T, Calabrese L, Antonelli E, Giuliani F, Corbeddu M, Galluzzo M.   +11 more
europepmc   +1 more source

Upadacitinib-Induced Remission in Multicentric Reticulohistiocytosis: Expanding the Therapeutic Role of JAK Inhibition. [PDF]

Int J Mol Sci
Pamfil C, Taki MA, Candrea E, Damian L, Mihon MI, Moldovan DMM, Rednic S.   +6 more
europepmc   +1 more source

P0800 Real-world use of upadacitinib in Inflammatory Bowel Disease patients in Greece: Focus on adverse events [PDF]

Antonios Neokleous, Athanasia Pagoni, Christos Liatsos, N Kyriakos, Eirini Zacharopoulou, K Tsokanta, A S Aravantinoy Koytsoyvi, M Tzouvala   +7 more
openalex   +1 more source

Real-World Comparative Efficacy and Safety of Upadacitinib, Tofacitinib, and Filgotinib in Patients With Ulcerative Colitis. [PDF]

Cureus
Ahmad F, Hussain T, Gunaratne CH, Collum J, Ghaffar A, Gharbia K.   +5 more
europepmc   +1 more source

Effective response to upadacitinib in patients affected by prurigo nodularis and by atopic dermatitis with a predominant prurigo nodularis pattern: A multicenter case series study [PDF]

Elena Pezzolo, Alessandra Narcisi, Luigi Gargiulo, Vito Di Lernia, Maddalena Napolitano, Cataldo Patruno, Simone Ribero, Michela Ortoncelli, Caterina Foti, Paolo Romita, Carlotta Gurioli, Donatella Schena, Silvia Mariel Ferrucci, Francesca Barei, Giuseppe Fabrizio Amoruso, Filomena Russo, Luigi Naldi   +16 more
openalex   +1 more source